SCHEMBL2275404

SCHEMBL2275404

CCOC(=O)c1nc2cnc3c(ccn3S(=O)(=O)c3ccccc3)c2n1C1CCN(Cc2ccccc2)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK1 P23458 2/20 0.45
JAK2 O60674 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.40
KMT2A Q03164 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
HTR6 P50406 2/20 0.38
MAOA P21397 2/20 0.38
PIK3C3 Q8NEB9 1/20 0.38
BCHE P06276 1/20 0.38
ACHE P22303 1/20 0.38
MAOB P27338 1/20 0.38
POLB P06746 1/20 0.37
ALDH1A1 P00352 3/20 0.37
KDM4E B2RXH2 1/20 0.37
LMNA P02545 1/20 0.37
TSHR P16473 1/20 0.37
PIK3CA P42336 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15006506 0.91 L3MBTL1 (0.38) JAK1JAK2KMT2ACYP3A4CYP2D6
SCHEMBL2274085 0.88 JAK1 (0.44) JAK1JAK2SMN1; SMN2KMT2ACYP3A4
SCHEMBL2279733 0.86 JAK1 (0.60) JAK1JAK2SMN1; SMN2HTR6POLB
SCHEMBL9952783 0.85 GABRA1 (0.40) JAK1JAK2KMT2APIK3C3ACHE
SCHEMBL2278249 0.85 JAK1 (0.43) JAK1JAK2SMN1; SMN2KMT2AHTR6
SCHEMBL20289924 0.84 JAK2 (0.48) JAK1JAK2
SCHEMBL21514467 0.84 JAK2 (0.48) JAK1JAK2
SCHEMBL21490651 0.84 JAK2 (0.48) JAK1JAK2
SCHEMBL12384868 0.84 HTR6 (0.37) JAK1JAK2KMT2ACYP2D6HTR6
SCHEMBL2278047 0.83 JAK2 (0.44) JAK1JAK2SMN1; SMN2HTR6POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2523957-A1 TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF F. Hoffmann-La Roche AG (CH) 2012-11-21 EP disclosed
WO-2011086053-A1 TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2011-07-21 WO disclosed